22nd Century Group Inc (XXII)

[sonwal]

An even better response to your question from Page 6 of the 22nd Century
document to the FDA.
Claim substantiation   

FDA’s preliminary scientific review of the application found that the threeproposed claims are substantiated: there is about a 95% reduction in 
nicotine in the tobacco itself, the smoke it yields, and the nicotine that is absorbed when the product is smoked exclusively. When the product is 
dual used with normal nicotine content cigarettes, nicotine exposure is 
still significantly reduced. In studies of smokers who do not intend to 
quit, compared to smokers assigned to a control condition where they  continue smoking usual brand cigarettes, smokers assigned to use the 
product reduce total number of cigarettes per day (CPD) by about 30% at 6 
weeks and 50% at 20 weeks.  

The FDA will approve this application because of the need to provide "choice" for those addicted to nicotine. It's time!

View entire document here: https://t.co/9ZbncjGZB4?amp=1